RecruitingPhase 3NCT05509777
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Sponsor: Eli Lilly and Company
Burlington, VT · +14 more sites
1 recruiting crohn's disease studies with a site in Burlington, VT.
Sponsor: Eli Lilly and Company
Burlington, VT · +14 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.